← back to search

Xiaoling Xu

Ministry of Education of the People's Republic of China · CN
Area of research
Molecular Biology · Geriatrics and Gerontology
Research interest
Research interests include Medicine, Internal medicine, Biology, Antibiotics, Metagenomics, and Confidence interval.
h-index
citations
1,671
works
5
NIH funding
primary concept
email

Recent publications

Enhanced efficacy of lung cancer treatment with radiotherapy and immune checkpoint inhibitors without increased pneumonia risk: a systematic review and meta-analysis of randomized controlled trials
Frontiers in Immunology 2025cited by 2position: lastdoi
CXCL12/CXCR4: An amazing challenge and opportunity in the fight against fibrosis
Ageing Research Reviews 2022cited by 89position: middledoi
Patient‐Derived Organoids Can Guide Personalized‐Therapies for Patients with Advanced Breast Cancer
Advanced Science 2021cited by 180position: middledoi
ZEB1 serves as an oncogene in acute myeloid leukaemia via regulating the PTEN/PI3K/AKT signalling pathway by combining with P53
Journal of Cellular and Molecular Medicine 2021cited by 27position: middledoi
LncRNA NR-104098 Inhibits AML Proliferation and Induces Differentiation Through Repressing EZH2 Transcription by Interacting With E2F1
Frontiers in Cell and Developmental Biology 2020cited by 35position: middledoi
ATPR induces acute promyelocytic leukemia cells differentiation and growth arrest by blockade of SHP2/Rho/ROCK1 pathway
Toxicology and Applied Pharmacology 2020cited by 9position: middledoi
A <i>DNAH17</i> missense variant causes flagella destabilization and asthenozoospermia
The Journal of Experimental Medicine 2019cited by 159position: middledoi
Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice
Clinical Infectious Diseases 2018cited by 885position: middledoi
Resveratrol treatment improves plasma and blood glucose concentration and lipid metabolism in high-fat-fed C57BL/6J mice
European Food Research and Technology 2016cited by 11position: middledoi
SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism
Cancer Cell 2013cited by 445position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Meiju Zhang · Ministry of Education of the People's Republic of China3 papers (2020–2021)Xiaoqing Peng · Nantong University3 papers (2020–2021)Yubin Feng · Ministry of Education of the People's Republic of China3 papers (2020–2021)Yan Du · Ministry of Education of the People's Republic of China3 papers (2020–2021)Tianxi Du · Ministry of Education of the People's Republic of China2 papers (2020–2020)Lanlan Li · Ministry of Education of the People's Republic of China2 papers (2020–2020)Feihu Chen · Nantong University2 papers (2020–2020) · 1 papers (2013–2013) · 1 papers (2013–2013)Yingnan Huang · Heilongjiang Provincial Environmental Science Research Institute1 papers (2018–2018)Jikang Liu · Ministry of Education of the People's Republic of China1 papers (2020–2020)Wangrui Lei · Ministry of Education of the People's Republic of China1 papers (2022–2022)Alfredo Csibi · Novartis (Switzerland)1 papers (2013–2013) · 1 papers (2013–2013)Chu‐Xia Deng · George Washington University1 papers (2013–2013)Jaewon J. Lee · Northern Territory Health Services1 papers (2013–2013)Ran Tang · Ministry of Education of the People's Republic of China1 papers (2022–2022)Xuewen Qian · Ministry of Education of the People's Republic of China1 papers (2020–2020)Marcia C. Haigis · Harvard University1 papers (2013–2013)Clary B. Clish · Broad Institute1 papers (2013–2013)